Millennium Management
GHDX

Millennium Management’s Genomic Health, Inc. GHDX Stock Holding History

Millennium Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-60,200
Closed -$1.91M – 3694
2013
Q2 		$1.91M Buy
+60,200
New +$1.98M 0.01% 1615

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Millennium Management's GHDX Position: Q3 2019 in Review

Millennium Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 705,141 shares — an estimated $41M sold.

Millennium Management first reported a position in GHDX in Q2 2013 and held it in 25 quarters. The position peaked at $72.9M in Q2 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Millennium Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Millennium Management sold 705,141 Genomic Health, Inc. shares in Q3 2019, an estimated $41M.
  • Millennium Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 25 quarters.
  • Millennium Management's Genomic Health, Inc. position peaked at $72.9M in Q2 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.